Clinical use of Libexin, a new peripheral antitussive
Rédey, T.; Skoda, E.
Therapia Hungarica 15(3): 117-119
1967
ISSN/ISBN: 0133-3909 PMID: 4866485 Document Number: 5106
Document emailed within 1 workday
Related Documents
Shul'gin, A.V.; Abramova, V.G.; Votchal, O.A. 1975: Clinical evaluation of the antitussive action of libexin and baltix Terapevticheskii Arkhiv 47(3): 140-142Vas, M.; Kun, A. 1967: A new antitussive (libexin) for geriatric use Therapia Hungarica 15(1): 32-34
Olivieri, D.; Giacomelli, P.; Montella, R.; Illiano, A.; Gargano, G.; Pamparana, F. 1983: Clinical study of a new antitussive: cloperastine Archivio Monaldi Per la Tisiologia E le Malattie Dell'apparato Respiratorio 38(5-6): 209-218
Taddei, M. 1971: Clinical trial of a delayed-action antitussive agent (Sinecod depot Hommel HH 10002) Schweizerische Rundschau für Medizin Praxis 60(17): 545-549
Packman, E.W.; London, S.J. 1980: The utility of artificially induced cough as a clinical model for evaluating the antitussive effects of aromatics delivered by inunction European Journal of Respiratory Diseases. Suppl 110: 101-109
Boselli, G. 1972: Clinical study of the activity and tolerance of hydropropizine, a drug with antitussive activity Minerva Medica 63(51): 2782-2788
Rácz, I.; Plachy, J.; Gyarmati, L. 1978: Libexin metabolism Acta Pharmaceutica Hungarica 48(Suppl): 11-13
Keszler, P.; Babanassi, E. 1968: Libexin in pulmonary surgery Therapia Hungarica 16(3): 130-132
Halmos, T.; Salamon, F. 1973: Observations with Libexin-c in bronchopulmonary syndromes Therapia Hungarica 21(3-4): 149-151
Csürös, L. 1989: Fifteen years of experience on the use of Libexin tablets Therapia Hungarica 37(1): 50-54
Schweiger, O. 1984: The role of Libexin combination in the symptomatic treatment of different pulmonary diseases Therapia Hungarica 32(2): 85-86
Ohkawa, H.; Iwakawa, T.; Ohtomo, N.; Kitayama, M.; Miyahara, A.; Matsuki, A. 1993: Clinical study on total intravenous anesthesia with droperidol, fentanyl, and ketamine--18. Effect on peripheral circulation as judged by core-peripheral temperature gradient Masui. Japanese Journal of Anesthesiology 42(4): 557-561
Gergely, I. 1978: Libexin combinatum in the treatment of patients suffering from chronic respiratory tract diseases Therapia Hungarica 26(3): 136-138
Lautt, W.W. 1999: Should clinical cardiologists report total peripheral resistance or total peripheral conductance? Canadian Journal of Cardiology 15(1): 45-47
Schelling, J.L. 1987: The use of antitussive agents Schweizerische Rundschau für Medizin Praxis 76(15): 409-410
Ciliberto, R.; Mazzaglia, E. 1975: Our experience with a new antitussive agent Minerva Pediatrica 27(28): 1551-1554
McGinnis, J.P. 1987: Review of the clinical and histopathologic features of four exophytic gingival lesions--the pyogenic granuloma, irritation fibroma, peripheral giant cell granuloma, and peripheral ossifying fibroma Journal - Oklahoma Dental Association 77(3): 25-30
Wójcicki, J.; Samochowiec, L.; Szwed, G.; Sawiński, J. 1975: The use of Duopect as expectorant--antitussive agent Archivum Immunologiae et Therapiae Experimentalis 23(1): 135-142
Montaguti, P.; Ceserani, R.; Bussi, R.; Cavalletti, E.; Tognella, S. 1994: Reproductive toxicology of the new antitussive moguisteine Arzneimittel-Forschung 44(12): 1347-1352
Christie, G.J.; Strom, P.W.; Rourke, J.E. 1980: Butorphanol tartrate: a new antitussive agent for use in dogs Veterinary Medicine-Small Animal Clinician 75(10): 1559-1562